1428
It was administered by 15 min infusion to 16 evaluable patients with non - small cell lung cancer ( NSCLC ) ( 7 with no prior treatment , 9 patients in relapse following surgery / radiotherapy ) at a dose ( 648 mg / m2 divided over 3 days , repeated every 3 weeks ) determined by phase I trial .
 Disease: non - small cell lung cancer; Disease: NSCLC
Given options, please tell me the categories of all the listed entity words.Output format is "type1: word1; type2: word2". 
Option: Disease, Chemical 
Text: {0} 
 Entities: non - small cell lung cancer, NSCLC 
Answer:
 Disease: non - small cell lung cancer; Disease: NSCLC